SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about board meeting

02 Jan 2019 Evaluate

As required under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Welcure Drugs & Pharmaceuticals has informed that the next meetings of the Audit Committee and the Board of Directors of the company will be held on Saturday, 12th January, 2019 to take on record the un-audited financial results for the quarter ended on December 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.32 -0.01 (-3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×